Liang-Fang Shen
Overview
Explore the profile of Liang-Fang Shen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
424
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liang Y, Liu X, Shen L, Hu G, Zou G, Zhang N, et al.
JAMA
. 2025 Mar;
PMID: 40079940
Importance: Approximately 20% to 30% of patients with locoregionally advanced nasopharyngeal carcinoma (NPC) experience disease relapse despite definitive chemoradiotherapy. The programmed cell death 1 (PD-1) blockade camrelizumab has demonstrated considerable...
2.
Xu C, Zhou G, Li W, Hu D, Chen X, Lin S, et al.
Cancer Cell
. 2025 Feb;
PMID: 40020668
Severe toxicities caused by concurrent cisplatin are a critical problem in nasopharyngeal carcinoma (NPC) treatment. In this phase 2 multicenter PLATINUM trial (NCT03984357), we recruited 152 NPC patients who received...
3.
Jiang W, Wang G, Qin G, Zhang W, Zhu X, Han Y, et al.
Cell Rep Med
. 2025 Feb;
6(2):101942.
PMID: 39938522
Advanced extranodal extension (ENE) in cervical lymph nodes (CLNs) increases the risk of distant metastasis in nasopharyngeal carcinoma (NPC). The 9th NPC staging system classifies N1/N2 patients with advanced CLN...
4.
Du X, Wang G, Zhu X, Han Y, Lei F, Shen L, et al.
Cancer Cell
. 2024 Jan;
42(3):464-473.e3.
PMID: 38242125
The AJCC/UICC TNM classification describes anatomic extent of tumor progression and guides treatment decisions. Our comprehensive analysis of 8,834 newly diagnosed patients with non-metastatic Epstein-Barr virus related nasopharyngeal carcinoma (NPC)...
5.
Zhang G, Li Y, Li N, Shen L, Li Z
Aging (Albany NY)
. 2022 Mar;
14(5):2348-2366.
PMID: 35273128
This study is aimed to establish a new glioma prognosis model by integrating the aging-related lncRNA expression profiles and clinical parameters of glioma patients enrolled in the Chinese Glioma Genome...
6.
Tang L, Chen Y, Chen C, Chen M, Chen N, Chen X, et al.
Cancer Commun (Lond)
. 2021 Oct;
41(11):1195-1227.
PMID: 34699681
Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor originating in the nasopharynx and has a high incidence in Southeast Asia and North Africa. To develop these comprehensive guidelines for the...
7.
Huang Z, Shi M, Wang W, Shen L, Tang Y, Rong Q, et al.
Radiother Oncol
. 2021 Jun;
161:191-197.
PMID: 34119586
Background: This study aimed to establish a nomogram for predicting locoregional recurrence (LRR) in breast cancer patients treated with neoadjuvant chemotherapy (NAC) and mastectomy. Methods: A total of 2368 patients...
8.
Chen Y, Liu X, Zhou Q, Yang K, Jin F, Zhu X, et al.
Lancet
. 2021 Jun;
398(10297):303-313.
PMID: 34111416
Background: Patients with locoregionally advanced nasopharyngeal carcinoma have a high risk of disease relapse, despite a high proportion of patients attaining complete clinical remission after receiving standard-of-care treatment (ie, definitive...
9.
Huang Z, Zhu L, Huang X, Tang Y, Rong Q, Shi M, et al.
Int J Radiat Oncol Biol Phys
. 2020 Jun;
108(4):1030-1039.
PMID: 32585337
Purpose: The present study aimed to evaluate the effect of postmastectomy radiation therapy (PMRT) after neoadjuvant chemotherapy in patients with node-positive stage II to III (cT1-4N1-2M0) breast cancer. Methods And...
10.
Jing D, Zhou W, Shen L, Zhang Q, Xie W, Shen E, et al.
Cancer Med
. 2019 Aug;
8(14):6344-6357.
PMID: 31464090
RIG-I is associated with the occurrence and development of many tumors. However, the role of RIG-I in radiotherapy and chemotherapy in NPC has not been reported to date. In our...